UFT and Oral Calcium Folinate as First-Line Chemotherapy for Metastatic Gastric Cancer
ByAlain Ravaud, MD, PhD,Markus M. Borner, MD,Jan H. M. Schellens, MD,Lionnel Geoffrois, MD,Patrick Schöffski, MD,Jantien Wanders, MD,Axel R. Hanauske, MD, PhD
Published: | Updated:
Locally advanced or metastatic adenocarcinoma of the stomach still carries a poor prognosis, with 5-year survival rates of < 15%. Palliative chemotherapeutic regimens for this disease are largely 5-FU–based. We